How to manage the left subclavian and left vertebral artery during TEVAR

Similar documents
How to Determine Tolerance for Branch Vessel Coverage

Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA

Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy. Johannes Lammer Medical University Vienna, Austria

Left subclavian artery revascularization: Society for Vascular Surgery Practice Guidelines

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

2 Aortic Arch Debranching UCSF Vascular Symposium /14/16. J Endovasc Ther 2002;9:suppl 2; II98 105

Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR

Development of a Branched LSA Endograft & Ascending Aorta Endograft

Subclavian artery Stenting

Technique and Outcome of Laser Fenestration For Arch Vessels

Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm

WHAT IS THE BEST OPTION FOR ARCH ANEURYSMS?

I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital

Acute Type B dissection. Closure of the infra diaphragmatic tear: how and when?

Thoracic endovascular aortic repair (TEVAR) is

Abdominal and thoracic aneurysm repair

Corporate Medical Policy

CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES

State of Art Hybrid Approach

Percutaneous Approaches to Aortic Disease in 2018

DISCLOSURES ISOLATED DTA LESION? TYPE B DISSECTIONS TREATMENT OPTIONS

The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations

Optimal repair of acute aortic dissection

Contemporary management of brachiocephalic occlusive disease. TM Sullivan Minneapolis, MN

Title. Different arch branched devices are available, is morphology the. main criteria of choice? Ciro Ferrer, MD

Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad).

Extent of Aortic Coverage and Incidence of Spinal Cord Ischemia After Thoracic Endovascular Aneurysm Repair

RETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery

Guidelines for Ultrasound Surveillance

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

Open fenestration for complicated acute aortic B dissection

COMPLICATIONS OF TEVAR

Experience of endovascular procedures on abdominal and thoracic aorta in CA region

Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui

SPINAL CORD ISCHEMIA AFTER THORACIC ANEURYSM REPAIR: RISK STRATIFICATION & PREVENTION DISCLOSURES. INDIVIDUAL None

Development of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection.

Reinhard Kopp, Karin Pfister, Beatrix Cucuruz, Konstantinos Gallis, Piotr M Kasprzak

Aortic Arch pathology options: Open,Hybrid, fenestration, Chimney or branched stent-graft?

What is the benefit. of MEP s in BEVAR for TAAA. in preventing paraplegia?

How to achieve a successful proximal sealing in TEVAR? Pr L Canaud

Treatment of acute type B aortic dissection: Current status

Management of the vertebral artery during thoracic endovascular aortic repair with coverage of the left subclavian artery

Results With a Selective Revascularization Strategy for Left Subclavian Artery Coverage During Thoracic Endovascular Aortic Repair

Management of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria

Acute dissections of the descending thoracic aorta (Debakey

Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here

Aortic Arch Treatment Open versus Endo Evidence versus Zeitgeist. M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria

Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair

Indications for stent grafts in type B aortic dissection

Aortic arch pathology. Cerebral ischemia following carotid artery stenosis.

Hybrid aortic arch repair

Advances in the treatment of posterior cerebral circulation symptomatic disease

TEVAR. (Thoracic Endovascular Aortic Repair) for Aneurysm and Dissection. Bruce Tjaden MD Vascular Surgery Fellow

Mechanisms of and treatment strategies for dsine after TEVAR for acute and chronic type B aortic dissection- insights from EuREC.

Medical Review Guidelines Magnetic Resonance Angiography

Residual Dissection and False Lumen Aneurysm After TEVAR

Comparison of Five Major Recent Endovascular Treatment Trials

Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation

Subclavian and Axillary Artery Aneurysms

The risk of air embolism in TEVAR and how to handle it!

Aortic Arch/ Thoracoabdominal Aortic Replacement

DIFFICULT ACCESS REMAINS A CONTRAINDICATION FOR EVAR APOSTOLOS K. TASSIOPOULOS, MD, FACS PROFESSOR AND CHIEF DIVISION OF VASCULAR SURGERY

Nellix Endovascular System: Clinical Outcomes and Device Overview

Left subclavian artery (LSA) coverage during

Modified candy-plug technique for chronic type B aortic dissection with aneurysmal dilatation: a case report

UC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery?

Daniela Branzan MD, Department of Vascular Surgery and Department of Interventional Angiology University Hospital Leipzig

Toward Total Endovascular Therapy of the Aorta. Adam W. Beck, MD. Associate Professor of Surgery Division of Vascular Surgery and Endovascular Therapy

Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies. Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018

No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

Animesh Rathore, MD 4/21/17. Penetrating atherosclerotic ulcers of aorta

Malperfusion Syndromes Type B Aortic Dissection with Malperfusion

Endovascular aortic stent grafts have forever

Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection

Ascending Aorta: The Endovascular Approach

EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury. Conflict of Interest. Hypotensive shock 5/5/2014. none

Surgical Considerations of TEVAR

Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

SAMPLE EDITION PELVIC AND LOWER EXTREMITY ARTERIES WITH ENDOVASCULAR REVASCULARIZATION. Cardiovascular Illustrations and Guidelines

TABLES. Table 1 Terminal vessel aneurysms. Table. Aneurysm location. Bypass flow** Symptoms Strategy Bypass recipient. Age/ Sex.

Overview of Subclavian & Innominate Artery Interventions

Presente e futuro negli aneurismi dell arco aortico

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation

STS/EACTS LatAm CV Conference 2017

Case Presentations: Advanced Thoracic Aortic Reconstructions. Eric Herget & Jehangir Appoo

Endovascular Treatment of Malperfusion Syndrome

Morbidity Audit and Logbook Tool SNOMED Board Reporting Terms for SET and IMG Vascular Surgery AMPUTATION AORTA

Treatment of Thoracoabdominal Aneurysms Is there a need for custom-made devices?

Thoracoabdominal Aorta: Advances and Novel Therapies

What is the best treatment for False Lumen growth after type B Dissection

Advances in Treatment of Traumatic Aortic Transection

Thoracic aortic trauma A.T.O.ABDOOL-CARRIM ACADEMIC HEAD VASCULAR SURGERY DEPARTMENT OF SURGERY UNIVERSITY OF WITWATERSRAND

Ascending Aorta: Is The Endovascular Approach Realistic?

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

The use of thoracic endovascular

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY:

Nicolas Bianchi M.D. May 15th, 2012

UC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures.

Transcription:

How to manage the left subclavian and left vertebral artery during TEVAR Jürg Schmidli Chief of Vascular Surgery Inselspital Hamburg 2017 Dept Cardiovascular Surgery, Bern, Switzerland

Disclosure No Disclosures Past President

Pathologies involving aortic segment 2, 3 and 4 Lee et al. Ann Thorac Surg. 2011

Introduction ü Up 40% of patients undergoing TEVAR have pathology that extends near the left subclavian artery (LSA) 1) ü dominant left vertebral artery (60% of patients) ü previous left internal mammary coronary artery bypass graft ü distal right vertebral segment is absent ü Prospective randomized trials directly comparing a selective strategy of LSA revascularization and routine LSA revascularization as well as other techniques of neuroprotection are unavailable and are needed. 1) Freezor et al., J Endovasc Ther 2007;14:568-73.

Neurologic injury with TEVAR Multifactorial Stroke may be caused by (1) systemic factors such as hypotension, hypertension, and anticoagulation (2) intracranial changes related to edema, cerebrospinal fluid drainage, or contrast/drug infusion (3) embolization of air, atheroma, or thrombus from the device or manipulation of devices within the aortic arch (4) interruption of forward blood flow from injury or coverage of arch vessels.

Imaging Assessment before TEVAR with intended covarage of the LSA ü CTA or MRA of thoracoabdominal aorta ü MRA of supraaortic and intracranial vessels ü Completeness of the Willisii circulus ü US of supraaortic vessels

Ultrasound studies After complete overstenting Complete reversed flow in ipsilateral vertebral artery in 70% of pts. Alternating flow profile in 25% of pts. Systolic deceleration: only few pts. After partial overstenting No pathologic changes detected E. Weigang, Mainz, VISAR 2007

Eur J Vasc Endovasc Surg (2017) 53, 176-184 10 studies 2594 patients pooled prevalence for stroke 4.1% (95% CI 2.9e5.5) LSA uncovered pooled stroke incidence 3.2% (95% CI 1.0e6.5)

ü 19 patients ü TEVAR, 8 with coverage of LSA ü In 63% new foci of restricted diffusion ü Overstenting of the left subclavian artery not associated with lateralization of lesions to one side Kahlert et al. Ann Thorac Surg 2014;98:53 8)

Expected symptoms after LSA coverage Neurologic symptoms Vertebrobasilar insufficiency Subclavian steal syndrome dizziness Left arm hypoperfusion Ischemia Rest pain Claudiaction

Reported symptoms after LSA coverage Neurological signs ü Vertebrobasilar insufficiency (24%) ü Subclavian steal syndrome ü Posterior cerebral strokes ü Cerebellar infarction ü Impaired binocular vision ü TIA with speech disorders ü Paraplegia/paraparesis Left arm hypoperfusion üischemia ürest pain üclaudiaction Si et al. Ann Vasc Surg 2014;28:851-9

The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: a systematic review and meta-analysis. ü 6% arm ischemia ü 4% spinal cord ischemia ü 2% vertebrobasilar ischemia ü 5% anterior circulation stroke ü 6% death Risk of coverage ü increase in the risk of paraplegia (odds ratio [OR], 2.69; 95% confidence interval [CI] 0.75-9.68) ü anterior circulation stroke (OR, 2.58; 95% CI, 0.82-8.09) ü Arm ischemia (OR, 47.7; 95% CI, 9.9-229.3) ü Vertebrobasilar ischemia (OR, 10.8; 95% CI, 3.17-36.7) Risk of revascularisation ü Incidence of phrenic nerve injury as a complication of primary revascularization was 4.40% (95% CI, 1.60%- 12.20%) ü no association with death, myocardial infarction, or transient ischemic attack. Rizvi et al. J Vasc Surg 2009;50:1159-69

64 y m 54 y m

ü MOTHER Registry ü 1002 patients ü Overall Stroke 2.2% ü Coverage LSA without revasc 9.1% ü Revasc before coverage 5.1% ü Coverage without revasc indipendently associated with stroke (odds ratio 3.5; 95% confidence interval [CI], 1.7-7.1) ü specifically in the posterior territory (OR, 11.7; 95% CI, 2.5-54.6) ü And previous cerebrovascular accident (OR, 7.1; 95% CI, 2.2-23.1) ü But not SCI

Eur J Vasc Endovasc Surg (2017) 53, 176-184 10 studies 2594 patients pooled prevalence for stroke 4.1% (95% CI 2.9-5.5) LSA uncovered pooled stroke incidence 3.2% (95% CI 1.0-6.5) LSA covered with revascularization pooled stroke incidence 5.3% (95% CI 2.6-8.6) LSA covered without revascularization Pooled stroke incidence 8.0% (95% CI 4.1-2.9)

ü 96 Patients ü 54 with revascularization (laser fenestration 33, bypass 11, trsp 10 ü 30d stroke rate overall 7.3%, SCI 2.1%, ü 30d stroke for LSA coverage without revasc 14.3% vs 1.9% (p=.02) ü 30 d SCI without revasc 4.8 % vs 0% (p=.11) J Vasc Surg 2017;65:1270-9

Opinion leaders: LSA revascularization before TEVAR I do it in every patient!

Carotid-Subclavian Bypass or Subclavian-Carotid Trsp in patients with TEVAR or without (isolated reconstruction) ü 30-day postoperative cerebrovascular accident (CVA) or death (CVA/D) ü Overall stroke, mortality, and combined CVA/D rates were for all 3.5% (n [ 31), 3.3% (n [ 29), and 5.8% (n [ 51), respectively ü Surgical approach did not affect outcome ü CVA/D rate was 10.2% (n [ 9) for revascularization in conjunction with TEVAR and 5.3% (n [ 42) for isolated reconstruction (P [.06).

82 Patients 32 LSA covered

ü 5 studies ü 1161 patients with LSA coverage ü 444 revascularization, 717 without ü Stroke rate, SCI rate and death rate not significantly different JEVT 2016, Vol. 23(4) 634 641

LSA repair techniques ü Carotid-subclavian Bypass ü Subclavian-carotid transposition lateral approach medial approach

Technique for subclavian to carotid transposition,tips, and tricks Mark D. Morasch, MD, Chicago, Ill J Vasc Surg 2009;49:251-4.

Ligation and division of thoracic duct J Vasc Surg 2009;49:251-4. Ligation and division of the vertebral vein.

J Vasc Surg 2009;49:251-4. Subclavian stump and transposition suture line. Mobilization of the subclavian artery and its proximal branches, inf. Thyroid art

J Vasc Surg 2009;49:251-4. Carotid to subclavian bypass Completed transposition.

Results- subclavian transposition n = 24 in-hospital mortality 0% neurologic injury 0% Gottardi et al. Ann Thorac Surg. 2008;86:1524-9

Results- double transposition n = 40 in-hospital mortality 2.5% neurologic injury 0% Gottardi et al. Ann Thorac Surg. 2008;86:1524-9

Results- total arch rerouting n = 17 in-hospital mortality 17% neurologic injury 5.8% retrograde type A aortic dissection!! Gottardi et al. Ann Thorac Surg. 2008;86:1524-9

Coverage of vertebral artery originating from the arch and LSA J Vasc Surg 2009;49:251-4. Surgical solution Completed transposition. Vertebral to carotid artery transposition by same exposure as for subcalvian to carotid artery transposition

Hybrid OR

SVS Practice Guidelines J Vasc Surg 2009;50:1155-8 Recommendation 1: In patients who need elective TEVAR where achievement of a proximal seal necessitates coverage of the left subclavian artery, we suggest routine preoperative revascularization, despite the very low-quality evidence (GRADE 2, level C) Recommendation 2: In selected patients who have an anatomy that compromises perfusion to critical organs, routine preoperative LSA revascularization is strongly recommended, despite the very low-quality evidence (GRADE 1, level C) Recommendation 3: In patients who need urgent TEVAR for life-threatening acute aortic syndromes where achievement of a proximal seal necessitates coverage of the left subclavian artery, we suggest that revascularization should be individualized and addressed expectantly on the basis of anatomy, urgency, and availability of surgical expertise (GRADE 2, level C).

ESVS descending aorta clinical practice guidelines Eur J Vasc Endovasc Surg (2017) 53, 4-52

LSA revascularization strongly recommended ü presence of a patent left internal mammary artery to coronary artery bypass graft ü termination of the left vertebral artery at the posterior inferior cerebellar artery or other discontinuity of the vertebrobasilar collaterals ü absent or diminutive or occluded right vertebral artery ü functioning arteriovenous shunt in the left arm ü prior infrarenal aortic repair with ligation of lumbar and middle sacral arteries ü planned long-segment (>20 cm) coverage of the descending thoracic aorta where critical intercostal arteries originate ü hypogastric artery occlusion ü presence of early aneurysmal changes that may require subsequent therapy involving the distal thoracic aorta. ü Left-handed professionals (e.g. piano player)

LSA revascularization not recommended ü Emergency TEVAR (no sufficient time) Type B aortic dissections with malperfusion traumatic aortic transsection ü Anatomic variations preclued revascularization Congenital anomalies such as aberrant arch anatomy abnormalities of the LSA or vertebral ü Post radiation therapy ü Expertise is not available

ü 160 patients underwent LSA closure or partial coverage ü 94 patients with partial LSA coverage during TEVAR, no treatment was provided ü 66 patients with full LSA coverage during TEVAR, right carotid artery-left common carotid artery bypass surgery was performed before TEVAR ü 10 patients, without any treatment for the vertebral artery, showing reverse blood flow of the left vertebral artery after surgery. ü 4 patients: Left common carotid artery-lsa bypass surgery was performed before TEVAR ü 3 patients: right common carotid artery-left common carotid artery-lsa bypass ü 6 out of these 7 patients underwent proximal LSA ligation ü In 160 patients, postoperative recurrent laryngeal nerve injury occurred in one patient ü No death J Thorac Dis 2017;9(5):1273-1280

Pooled odds ratios (POR) postoperative CVA and SCI. ü CVA without LSA coverage without revasc vs non-coverage (4.7% vs 2.7%; POR, 2.28; 95% confidence interval [CI], 1.28-4.09; P <.005) ü CVA in LSA coverage after revascularization vs non-coverage (4.1% vs 2.6%; POR, 3.18; 95% CI, 1.17-8.65; P <.02). ü The risk of SCI with LSA coverage without revasc vs noncoverage (2.8% vs 2.3%; POR, 2.39; 95% CI, 1.30-4.39; P <.005) ü SCI in LSA coverage after revascularization vs non-coverage (0.8% vs 2.7%; POR, 1.69; 95% CI, 0.56-5.15; P <.35). J Vasc Surg 2009;49:1594-601